You already know that sun protection is non-negotiable for pigment. Broad-spectrum SPF, reapplication, visible light protection with iron oxides or tinted formulas, heat management. All of that matters and none of it is being replaced by anything here.
What most people do not know is that there is a complementary layer. Compounds taken orally that support your skin's resilience to UV damage from the inside, reducing the oxidative and inflammatory response that UV triggers in your skin tissue before your topical sunscreen even enters the equation.
This is not fringe science. There are clinical trials. And for women managing melasma or sun-reactive pigment, it is worth knowing about.
What oral photoprotection actually means
Your skin's response to UV is not just about the rays hitting the surface. When UV reaches your skin cells, it triggers a response: ROS generation, DNA damage, inflammatory mediator release, and melanocyte activation. Your sunscreen blocks a significant portion of UV before it reaches your skin. But no sunscreen is perfect. Some UV gets through, visible light gets through (standard chemical SPF does not block it), and infrared heat reaches your skin regardless.
Oral photoprotection works on the response side. It does not block UV from reaching your skin. It supports your skin's ability to handle the UV that gets through with less oxidative damage, less inflammation, and less melanocyte activation. Think of it as resilience rather than barrier.
Polypodium leucotomos: the centrepiece
This is a tropical fern extract that has been used in Central and South American traditional medicine for skin conditions for decades, and it now has a meaningful body of clinical research behind it.
The mechanism is multi-pathway. Polypodium leucotomos reduces UV-induced ROS production, calms the inflammatory response to UV exposure, and may reduce UV-induced DNA damage. Multiple clinical trials have shown that oral Polypodium leucotomos, taken before UV exposure, reduces the skin's erythemal response (sunburn) and the inflammatory response that follows.
For hyperpigmentation specifically, there is clinical evidence showing benefit in melasma patients when Polypodium leucotomos is combined with topical treatment and sun protection. The proposed mechanism is that by reducing the UV-triggered inflammatory and oxidative stress that drives melanocyte activation, it reduces the ongoing stimulus that keeps melasma flaring.
At a 10:1 extract concentration, meaning the active compounds are concentrated tenfold relative to the raw plant material, you need less volume to deliver a clinically relevant dose. The research supporting effectiveness typically uses extracts at standardised concentrations, and the dosing that has shown results in clinical settings is well within what concentrated extracts can deliver.
The supporting cast
Polypodium leucotomos does not work in isolation. The broader antioxidant and anti-inflammatory network supports the same response from different angles.
Beta carotene (provitamin A) accumulates in the skin over time and has documented photoprotective properties. The level of protection is modest, but it contributes to the skin's baseline resilience to oxidative damage from UV. Think of it as part of the foundation rather than the main structure.
The antioxidant network (vitamin C, vitamin E, selenium, polyphenols from tea and pomegranate, resveratrol) collectively reduces the oxidative damage that UV triggers in your skin tissue. UV generates ROS. Antioxidants neutralise ROS. The more effective your systemic antioxidant capacity, the less oxidative signalling reaches your melanocytes after UV exposure.
Together, these compounds support a systemic environment where UV exposure produces less downstream melanocyte activation than it otherwise would. Not zero activation. Less activation. And for pigment that is being maintained by cumulative UV-driven signalling, "less" is often the difference between plateau and progress.
What this does not replace
Let's be clear. Oral photoprotection is not a sunscreen. It does not block UV. It does not replace broad-spectrum SPF, it does not replace reapplication, and it does not replace visible light protection (iron oxide tints for visible light, physical shade for heat).
What it does is add a layer beneath all of that. Your sunscreen handles what it can on the outside. The internal support handles the residual oxidative and inflammatory response to whatever gets through. For women dealing with melasma who are already doing everything right with external protection and still seeing flares, this complementary layer is often the piece that makes the difference.
Sun protection starts on the outside. It can also be supported from the inside. Oral photoprotection is not a replacement for what you already do. It is the layer beneath it that most people do not know exists.
